Involvement of the Kappa-opioid Receptor in Nitrous Oxide-induced Analgesia in Mice

Overview

Journal J Anesth

Specialty Anesthesiology

Date 2010 Feb 17

PMID 20157832

Citations 2

Authors

Tomohiro Koyama

Kazuhiko Fukuda

Affiliations

Soon will be listed here.

Abstract

Nitrous oxide (N(2)O)-induced analgesia is thought to be mediated by endogenous opioids. We previously showed that the mu-opioid receptor is not required for the analgesic action of N(2)O in mice using a gene knockout approach. In this study, we examined the effect of kappa- (KOP)- or delta-opioid receptor (DOP)-selective antagonists on N(2)O-induced analgesia. The analgesic effect of N(2)O was evaluated using a writhing test. Male C57BL/6 mice aged 7-8 weeks were assigned to control, N(2)O, KOP agonist, and DOP agonist groups. According to the group assignment, mice were pretreated with a KOP antagonist, nor-binaltorphimine (nor-BNI), a DOP antagonist, naltrindole hydrochloride (NTI), a KOP agonist U50488, and a DOP agonist SNC80. Mice in the control, KOP agonist, and DOP agonist groups were exposed to 25% oxygen/75% nitrogen for 30 min, and mice in the N(2)O group were exposed to 25% oxygen/75% N(2)O for 30 min. Nor-BNI [10 mg kg(-1), subcutaneously (s.c.)] significantly suppressed the analgesic effect of N(2)O and U50488. In contrast, NTI (10 mg kg(-1) s.c.) did not significantly affect the analgesic action of N(2)O, but almost completely inhibited the analgesic effect of SNC80. These results suggest that KOP plays an important role in the analgesic effect of N(2)O in mice.

Citing Articles

N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

Richardson K, Shelton K J Pharmacol Exp Ther. 2014; 352(1):156-65.

PMID: 25368340 PMC: 4279098. DOI: 10.1124/jpet.114.218057.

The effect of nitrous oxide on the minimum alveolar concentration (MAC) and MAC derivatives of isoflurane in dogs.

Voulgaris D, Egger C, Seddighi M, Rohrbach B, Love L, Doherty T Can J Vet Res. 2013; 77(2):131-5.

PMID: 24082405 PMC: 3605929.

References

Georgiev S, Kohno T, Ikoma M, Yamakura T, Baba H . Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons. Pain. 2007; 134(1-2):24-31. DOI: 10.1016/j.pain.2007.03.026. View

Endoh T, Matsuura H, Tanaka C, Nagase H . Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther. 1992; 316:30-42. View

Ossipov M, Kovelowski C, Vanderah T, Porreca F . Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat. Neurosci Lett. 1994; 181(1-2):9-12. DOI: 10.1016/0304-3940(94)90548-7. View

Portoghese P, Lipkowski A, TAKEMORI A . Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 1987; 40(13):1287-92. DOI: 10.1016/0024-3205(87)90585-6. View

Quock R, Best J, Chen D, Vaughn L, Portoghese P, TAKEMORI A . Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors. Eur J Pharmacol. 1990; 175(1):97-100. DOI: 10.1016/0014-2999(90)90158-3. View

Branda E, Ramza J, Cahill F, TSENG L, Quock R . Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 2000; 65(2):217-21. DOI: 10.1016/s0091-3057(99)00202-6. View

Berkowitz B, NGAI S, Finck A . Nitrous oxide "analgesia": resemblance to opiate action. Science. 1976; 194(4268):967-8. DOI: 10.1126/science.982058. View

Fujinaga M, Maze M . Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002; 25(2):167-89. DOI: 10.1385/MN:25:2:167. View

TAKEMORI A, Ho B, Naeseth J, Portoghese P . Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther. 1988; 246(1):255-8. View

10.

Koyama T, Mayahara T, Wakamatsu T, Sora I, Fukuda K . Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth. 2009; 103(5):744-9. DOI: 10.1093/bja/aep246. View

11.

Portoghese P, Sultana M, TAKEMORI A . Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol. 1988; 146(1):185-6. DOI: 10.1016/0014-2999(88)90502-x. View

12.

Yamakura T, Harris R . Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology. 2000; 93(4):1095-101. DOI: 10.1097/00000542-200010000-00034. View

13.

Mukaida K, Shichino T, Fukuda K . Nitrous oxide increases serotonin release in the rat spinal cord. J Anesth. 2007; 21(3):433-5. DOI: 10.1007/s00540-007-0511-4. View

14.

VonVoigtlander P, Lahti R, Ludens J . U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. J Pharmacol Exp Ther. 1983; 224(1):7-12. View

15.

Bilsky E, Calderon S, Wang T, Bernstein R, Davis P, Hruby V . SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther. 1995; 273(1):359-66. View

16.

Gruss M, Bushell T, Bright D, Lieb W, Mathie A, Franks N . Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004; 65(2):443-52. DOI: 10.1124/mol.65.2.443. View

17.

Fields H . State-dependent opioid control of pain. Nat Rev Neurosci. 2004; 5(7):565-75. DOI: 10.1038/nrn1431. View

18.

Kingery W, Sawamura S, Agashe G, Davies M, Clark J, Zimmer A . Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide. Eur J Pharmacol. 2001; 427(1):27-35. DOI: 10.1016/s0014-2999(01)01193-1. View

19.

Sanders R, Weimann J, Maze M . Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008; 109(4):707-22. DOI: 10.1097/ALN.0b013e3181870a17. View

20.

Pan Z . mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci. 1998; 19(3):94-8. DOI: 10.1016/s0165-6147(98)01169-9. View